Abiopharma

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004

GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

Veeva and BioMarin Form Long-Term Strategic Partnership

VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders

New Form SCHEDULE 13G/A - SCYNEXIS INC Filed: 2026-01-08 AccNo: 0001623632-26-000036 Size: 46 KB

New Form SCHEDULE 13G/A - IDEAYA Biosciences, Inc. Filed: 2026-01-08 AccNo: 0001623632-26-000034 Size: 47 KB

(85% Positive) Voyager Therapeutics, Inc. (VYGR) Files Form 8-K

(99% Neutral) CORMEDIX INC. (CRMD) Reports Q1 2026 Financial Results

New Form SCHEDULE 13G/A - Arcturus Therapeutics Holdings Inc. Filed: 2026-01-08 AccNo: 0001623632-26-000033 Size: 46 KB

(99% Neutral) Coya Therapeutics, Inc. (COYA) Announces Clinical Development Update

ProQR Therapeutics (PRQR) Files Form 6-K

ProQR Press Release: ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook

(100% Positive) COLLEGIUM PHARMACEUTICAL, INC. (COLL) Announces Business Combination

(80% Positive) Century Therapeutics, Inc. (IPSC) Provides Update on program for Type 1 Diabetes PHILADELPHIA

(90% Positive) XENCOR, INC. (XNCR) Announces Enrollment Update for data Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment